Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities

This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the...

Safe’n’Spray: Winner at CPhI Festival of Pharma

Nemera’s  concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October 2020 on the digital platform of CPhI Festival of Pharma. Safe’n’Spray is...

UCLB spinout Freeline Closes $120 Million Series C Financing Round

Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline of $40 million (£30.6 million) with an additional...

Arctoris and Syntekabio Form Research Partnership

Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of Understanding with listed Korean company Syntekabio, Inc. to collaborate on drug discovery efforts. The first project under...

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Next Generation ADC Uses Proprietary Technologies Aimed at Enhancing Cancer Therapy Efficacy and Safety Nijmegen, The Netherlands – 11 August 2020 – Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients...

UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S....

London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company,...

Nemera takes dermal treatments to millions of patients

Nemera is a world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, including complex dermal drug delivery devices. Dermal pharmaceuticals, cosmetics and personal hygiene products all...

Nemera and Noble announce collaboration to support patients who self-administer medication

 Nemera is excited to leverage the new collaboration to expand end-to-end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices  Nemera, world leader in design, development and manufacturing of drug...

UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids

Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a breathing aid developed by UCL, UCLH and Mercedes-AMG High...

FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene...

Capabilities expand to supplying plasmids for triple transfections BILLINGHAM, United Kingdom, April 23, 2020 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the...

IBM releases novel AI-powered technology to accelerate medical research for COVID-19

IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery. These novel resources, from across IBM and available beginning today (Friday 3 April)...

Nemera acquires Insight Product Development to strengthen its capabilities in early stage development and...

We are pleased to announce that Nemera has completed the acquisition of Insight Product Development, a 100% healthcare focused design and innovation consulting firm based in Chicago, IL (USA). Insight delivers innovation in both medical...

A first launch on OTC drugs with Advancia®!

After the successful launch of Nemera’s next generation nasal spray pump within its Crimp-on version, Advancia® Snap-on version is now on the South Korean market with an intranasal decongestant nasal spray. JW Pharmaceutical has recently...

Safe’n’Spray™, the smart electronic concept device with child-resistant and locking features, wins the ‘Best...

A team of industry experts awarded Nemera’s Safe’n’Spray with a prestigious Pharmapack Award for ‘Best Innovation in Drug Delivery Device’. On February 5th, during the Pharmapack Awards Ceremony, Safe’n’Spray, Nemera’s smart electronic concept device with...

Betrayed by bile: bile acids help norovirus sneak into cells

A new study led by researchers at Baylor College of Medicine and published in the Proceedings of the National Academy of Sciences reveals that human noroviruses, the leading viral cause of foodborne illness and...

Hyperactive FOXA1 reprograms endocrine-resistant breast cancer to become metastatic

A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new...